Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia

Study acronym: DUAL-VT
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre to McGill University Health Centre/Research Institute of the McGill University Health Centre
    • Primary completion date changed from estimate of Jul 2026 to Sep 30, 2026
    • Study completion pushed from Aug 2026 to Jan 2027
    • Eligibility criteria expanded, about 25 words
  2. Trial status changed: Recruiting → Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    v4
  3. Site details revised at 1 of 3 sitesv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2025 to Jul 28, 2025
    • Secondary endpoints: 3 to 2
    • Site details revised at 3 of 3 sites
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This will be a single arm study evaluating a new ablation technology for performing catheter ablation of ventricular tachycardia. The technology combines novel pulsed field ablation with radiofrequency ablation.
Trial Details
NCT Number NCT06816368
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions
(from sponsor)		 Ventricular Tachycardia (V-Tach)
Related terms Tachycardia, Ventricular
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov